Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2007
02/28/2007EP1757935A1 Gene detection method and gene detection apparatus
02/28/2007EP1757934A1 Method for screening compounds against flaviviruses by using persistent virus-infected cell system
02/28/2007EP1757933A1 Method for the determination of body odor
02/28/2007EP1757932A2 Ion channel assay methods
02/28/2007EP1757927A2 Method and apparatus for measuring the presence of cooling lubricant material in the atmosphere.
02/28/2007EP1757922A1 Device and method for sorting biological particles
02/28/2007EP1757705A2 Intraoperative lymph node assay
02/28/2007EP1757704A2 Methods for detecting mutations associated with hypertrophic cardiomyopathy
02/28/2007EP1757696A2 Group B streptococcus proteins, and their use
02/28/2007EP1757695A2 Prostate-specific membrane antigen
02/28/2007EP1757694A2 Prostate-specific membrane antigen
02/28/2007EP1757693A2 Nucleic acids showing difference in expression between hepatoblastoma and normal liver
02/28/2007EP1757692A1 GENE ENCODING GUANINE NUCLEOTIDE EXCHANGE FACTOR BINDING TO RhoA
02/28/2007EP1757691A1 Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103
02/28/2007EP1757690A1 Gene encoding guanine nucleotide exchange factor and its gene product
02/28/2007EP1757689A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
02/28/2007EP1757640A1 Thermoplastic plastic and method for producing the same
02/28/2007EP1757622A1 Bivalent IgY antibody constructs for diagnostic and therapeutic applications
02/28/2007EP1757621A2 Compositions and methods for the treatment and diagnosis of immune disorders
02/28/2007EP1757620A2 Cancerous disease modifying antibodies
02/28/2007EP1757617A1 Ret Ligand (RetL) for stimulating neural and renal growth
02/28/2007EP1757616A2 Semaphorin receptors
02/28/2007EP1757349A1 Multi-analyte affinity column
02/28/2007EP1757306A1 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes
02/28/2007EP1757302A1 Adiponectin expression inducer and utilization of the same
02/28/2007EP1757295A1 Peripheral-Type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
02/28/2007EP1757269A2 Pulmonary formulation comprising silicon particles
02/28/2007EP1756852A2 Method and apparatus for identifying proteins in mixtures
02/28/2007EP1756597A1 Device for determining composition of a fluid mixture
02/28/2007EP1756585A2 Method of high throughput screening of anitoxidants at near ambient temperatures
02/28/2007EP1756584A2 Enriched pag-55 fraction and methods for early detection of pregnancy in ungulate animals
02/28/2007EP1756583A2 Prognostic methods for congestive heart failure
02/28/2007EP1756582A1 Markers for atherosclerosis
02/28/2007EP1756581A1 Method for the detection of disease-related prion
02/28/2007EP1756580A1 Reagents, devices and methods for proteomic analysis with applications including diagnostics and vaccines
02/28/2007EP1756579A2 Collections of traceable compounds and uses thereof
02/28/2007EP1756578A2 Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
02/28/2007EP1756577A2 Methods and compositions for the detection of cervical disease
02/28/2007EP1756576A1 Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 10 (dpp10)
02/28/2007EP1756575A2 Detection of methamphetamine group drugs
02/28/2007EP1756574A1 Method
02/28/2007EP1756573A1 Adsorption agent for nucleic acids containing acid-activated phyllosilicate
02/28/2007EP1756572A1 A device for binding a target entity to a bait entity and detection methods using the same
02/28/2007EP1756571A2 Real time method of detecting acute inflammatory conditions
02/28/2007EP1756570A2 Immunoassays for buprenorphine and norbuprenorphine
02/28/2007EP1756569A1 Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis
02/28/2007EP1756568A1 Improved diagnostic testing apparatus
02/28/2007EP1756567A2 Biological soil detector and method of using same
02/28/2007EP1756566A2 Biomarkers for ovarian cancer
02/28/2007EP1756564A2 High-temperature gas sensors and their use in exhaust gases
02/28/2007EP1756558A1 Micro-band electrode manufacturing method
02/28/2007EP1756557A1 Electrochemical cell and method of making an electrochemical cell
02/28/2007EP1756556A1 Gas sensor for determining ammonia
02/28/2007EP1756554A1 Biomarkers for peripheral artery disease
02/28/2007EP1756548A1 Biosensor using whispering gallery modes in microspheres
02/28/2007EP1756546A1 Measurement of an object
02/28/2007EP1756545A2 Frozen tissue microarray
02/28/2007EP1756317A2 Methods for identifying risk of osteoarthritis and treatments thereof
02/28/2007EP1756309A2 Methods for predicting and monitoring response to cancer therapy
02/28/2007EP1756301A1 A method for monitoring the progress of cancer
02/28/2007EP1756297A2 High throughput reactive oxygen species-based cytochrome p450 inhibition assay
02/28/2007EP1756295A1 Biological soil detector and method of using same
02/28/2007EP1756278A2 Method of improving t cell receptors
02/28/2007EP1756270A2 Diagnosis and treatment of myeloid and lymphoid cell cancers
02/28/2007EP1756166A1 Prostate cancer diagnosis and treatment
02/28/2007EP1756165A2 Tissue-specific imaging and therapeutical agents targeting proteins expressed on lung endothelial cell surface
02/28/2007EP1756157A1 Gerbil neurokinin 1 receptor
02/28/2007EP1756147A2 Peptides for inducing a ctl and/or htl response to hepatitis c virus
02/28/2007EP1756144A2 Isolated nucleic acid molecules encoding a novel phosphoprotein-darpp-32, encoded protein and uses thereof
02/28/2007EP1756137A2 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
02/28/2007EP1756119A1 Collection of traceable compounds and uses thereof
02/28/2007EP1756034A2 Antibiotic compound
02/28/2007EP1755669A2 Methods and compositions for specifically targeting human hepatocellular carcinoma cells
02/28/2007EP1755667A2 Stable peptide mimetic of hiv gp41 fusion intermediate
02/28/2007EP1755662A2 Combined meningococcal conjugates with common carrier protein
02/28/2007EP1755660A2 Method for enhancing or inhibiting insulin-like growth factor-i
02/28/2007EP1755653A2 Treatment methods utilizing albumin-binding proteins as targets
02/28/2007EP1755649A1 Selective killing of cancer cells by induction of acetyltransferase via tnf-alpha and il-6
02/28/2007EP1755377A2 Scent identification apparatus and method
02/28/2007EP1706720A4 Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
02/28/2007EP1695069A4 Hydrogen sulfide monitoring system
02/28/2007EP1633381A4 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity
02/28/2007EP1579013A4 Method for profiling and identifying persons by using data samples
02/28/2007EP1578778A4 Ghrelin analogs
02/28/2007EP1570266B1 Methods for measuring the activity of g(alpha)i-coupled or g(alpha)o-coupled receptors by means of the ca2+ influx in cells
02/28/2007EP1539803B1 Fluoro-alkyl-cyclopeptide derivatives having anti-integrin activity
02/28/2007EP1518117B1 Method for diagnosing and treating nis-expressing carcinomas and metastases
02/28/2007EP1471355B1 Method of fixing biomolecule to carrier
02/28/2007EP1466015A4 Bioconjugate-nanoparticle probes
02/28/2007EP1410055B1 Method and device for analysing the intracellular chemical state of living cells by nuclear magnetic resonance
02/28/2007EP1390500A4 Transgenic non-human animals for pharmacological and toxicological studies
02/28/2007EP1368094B1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a|-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands
02/28/2007EP1339496B1 Sample delivery system with laminar mixing for microvolume biosensing
02/28/2007EP1337258A4 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof
02/28/2007EP1327143B1 Crystal structure of bace and uses thereof
02/28/2007EP1313876B8 Process for detecting acetylase or deacetylase activity in an immunoassay
02/28/2007EP1294760B1 Heliothis glutamate receptor
02/28/2007EP1279026B1 Method in connection with the production of pulp, paper or paperboard
02/28/2007EP1255967B1 Device for measuring mass flow and energy content
02/28/2007EP1254240B1 Hybrid protease with reduced antigenicity and its use
1 ... 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 ... 3937